CN115961102A - 基于era技术的对虾传染性肌肉坏死病毒的检测方法 - Google Patents
基于era技术的对虾传染性肌肉坏死病毒的检测方法 Download PDFInfo
- Publication number
- CN115961102A CN115961102A CN202211704566.3A CN202211704566A CN115961102A CN 115961102 A CN115961102 A CN 115961102A CN 202211704566 A CN202211704566 A CN 202211704566A CN 115961102 A CN115961102 A CN 115961102A
- Authority
- CN
- China
- Prior art keywords
- era
- amplification
- muscle necrosis
- prawn
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 52
- 241000238557 Decapoda Species 0.000 title claims abstract description 50
- 208000015181 infectious disease Diseases 0.000 title claims abstract description 45
- 230000002458 infectious effect Effects 0.000 title claims abstract description 43
- 206010028320 muscle necrosis Diseases 0.000 title claims abstract description 40
- 241000700605 Viruses Species 0.000 title claims abstract description 30
- 238000005516 engineering process Methods 0.000 title claims abstract description 19
- 230000003321 amplification Effects 0.000 claims abstract description 75
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 75
- 239000000523 sample Substances 0.000 claims abstract description 42
- 238000006243 chemical reaction Methods 0.000 claims abstract description 33
- 238000000034 method Methods 0.000 claims abstract description 23
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 14
- 101710121996 Hexon protein p72 Proteins 0.000 claims abstract description 8
- 101710125418 Major capsid protein Proteins 0.000 claims abstract description 8
- 239000003153 chemical reaction reagent Substances 0.000 claims description 9
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical group CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 claims description 8
- 238000011144 upstream manufacturing Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 4
- 239000002773 nucleotide Substances 0.000 claims description 4
- 125000003729 nucleotide group Chemical group 0.000 claims description 4
- 239000012190 activator Substances 0.000 claims description 3
- 230000002101 lytic effect Effects 0.000 claims description 3
- 238000010791 quenching Methods 0.000 claims description 3
- 230000000171 quenching effect Effects 0.000 claims description 3
- 125000006853 reporter group Chemical group 0.000 claims description 3
- WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical group C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 abstract description 10
- 238000013461 design Methods 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- 239000013612 plasmid Substances 0.000 description 17
- 238000007857 nested PCR Methods 0.000 description 11
- 238000003757 reverse transcription PCR Methods 0.000 description 11
- 206010028851 Necrosis Diseases 0.000 description 9
- 230000017074 necrotic cell death Effects 0.000 description 9
- 108020004414 DNA Proteins 0.000 description 7
- 108020004707 nucleic acids Proteins 0.000 description 7
- 102000039446 nucleic acids Human genes 0.000 description 7
- 150000007523 nucleic acids Chemical class 0.000 description 7
- 241000696962 White spot syndrome virus Species 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000000246 agarose gel electrophoresis Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 238000011901 isothermal amplification Methods 0.000 description 5
- 244000052769 pathogen Species 0.000 description 5
- 238000003556 assay Methods 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 238000007397 LAMP assay Methods 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 108060002716 Exonuclease Proteins 0.000 description 2
- 241000238553 Litopenaeus vannamei Species 0.000 description 2
- 108060004795 Methyltransferase Proteins 0.000 description 2
- 108700026244 Open Reading Frames Proteins 0.000 description 2
- 241000006445 Penaeus vannamei nodavirus Species 0.000 description 2
- 102000018120 Recombinases Human genes 0.000 description 2
- 108010091086 Recombinases Proteins 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 102000013165 exonuclease Human genes 0.000 description 2
- 230000003394 haemopoietic effect Effects 0.000 description 2
- 238000010562 histological examination Methods 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 108090000565 Capsid Proteins Proteins 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 101001081251 Drosophila melanogaster Protein held out wings Proteins 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241001126836 Enterocytozoon Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000710938 Giardiavirus Species 0.000 description 1
- 101000833492 Homo sapiens Jouberin Proteins 0.000 description 1
- 101000651236 Homo sapiens NCK-interacting protein with SH3 domain Proteins 0.000 description 1
- 102100024407 Jouberin Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 101710159752 Poly(3-hydroxyalkanoate) polymerase subunit PhaE Proteins 0.000 description 1
- 101710130262 Probable Vpr-like protein Proteins 0.000 description 1
- 101150016678 RdRp gene Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 241000710914 Totivirus Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000012197 amplification kit Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 229940069446 magnesium acetate Drugs 0.000 description 1
- 235000011285 magnesium acetate Nutrition 0.000 description 1
- 239000011654 magnesium acetate Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000001821 nucleic acid purification Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000012803 optimization experiment Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 108010068698 spleen exonuclease Proteins 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211704566.3A CN115961102A (zh) | 2022-12-29 | 2022-12-29 | 基于era技术的对虾传染性肌肉坏死病毒的检测方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211704566.3A CN115961102A (zh) | 2022-12-29 | 2022-12-29 | 基于era技术的对虾传染性肌肉坏死病毒的检测方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115961102A true CN115961102A (zh) | 2023-04-14 |
Family
ID=87363054
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211704566.3A Pending CN115961102A (zh) | 2022-12-29 | 2022-12-29 | 基于era技术的对虾传染性肌肉坏死病毒的检测方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115961102A (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108103240A (zh) * | 2017-11-10 | 2018-06-01 | 杭州众测生物科技有限公司 | 对虾传染性肌肉坏死病毒(imnv)的raa恒温荧光检测方法及试剂 |
-
2022
- 2022-12-29 CN CN202211704566.3A patent/CN115961102A/zh active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108103240A (zh) * | 2017-11-10 | 2018-06-01 | 杭州众测生物科技有限公司 | 对虾传染性肌肉坏死病毒(imnv)的raa恒温荧光检测方法及试剂 |
Non-Patent Citations (3)
Title |
---|
SHYAM KOKKATTUNIVARTHIL等: "New set of PCR primers for SYBR green-based qPCR detection of IMNV in India", AQUACULTUR, vol. 495, pages 2 * |
T P D ANDRADE等: "Development of a method for the detection of infectious myonecrosis virus by reverse-transcription loop-mediated isothermal amplification and nucleic acid lateral flow hybrid assay", JOURNAL OF FISH DISEASES, vol. 32, pages 911 - 924 * |
王帅 等: "RPA、RAA及ERA技术在食源性致病菌快速检测中的研究进展", 食品科学, pages 1 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Dhar et al. | Detection and quantification of infectious hypodermal and hematopoietic necrosis virus and white spot virus in shrimp using real-time quantitative PCR and SYBR Green chemistry | |
Chen et al. | Detection of shrimp hemocyte iridescent virus by recombinase polymerase amplification assay | |
CN108060269B (zh) | 用于猪流行性腹泻病毒、猪传染性胃肠炎病毒以及猪轮状病毒检测的dpo引物组及其应用 | |
Tsai et al. | Validation of a commercial insulated isothermal PCR-based POCKIT test for rapid and easy detection of white spot syndrome virus infection in Litopenaeus vannamei | |
CN108676920B (zh) | 一种快速检测小鼠诺如病毒引物、试剂盒及其rt-rpa方法 | |
CN108330210B (zh) | 寨卡病毒、登革热病毒和基孔肯雅病毒核酸检测试剂盒及其用途 | |
CN111534637B (zh) | 肠道病毒核酸检测的通用引物和探针以及试剂盒 | |
Zhu et al. | Multiplex and visual detection of African Swine Fever Virus (ASFV) based on Hive-Chip and direct loop-mediated isothermal amplification | |
CN110643745A (zh) | 一种用于检测猫杯状病毒和猫细小病毒的组合物、试剂盒及其应用 | |
CN112877476A (zh) | 非洲猪瘟病毒p72基因荧光探针pcr检测引物探针组、试剂盒及方法 | |
CN112430686A (zh) | 用于同时检测bvdv-1、bvdv-2和bvdv-3的试剂盒及引物和探针 | |
Huang et al. | Establishment of a real-time Recombinase Polymerase Amplification (RPA) for the detection of decapod iridescent virus 1 (DIV1) | |
CN113046484B (zh) | 用于检测非洲猪瘟病毒p72基因的引物探针、试剂盒及方法 | |
Tong et al. | Rapid detection of Decapod iridescent virus 1 (DIV1) by recombinase polymerase amplification | |
CN114015813A (zh) | 一种基于rpa等温扩增技术鉴别非洲猪瘟病毒的方法及试剂盒 | |
Chen et al. | Improved one-tube RT-PCR method for simultaneous detection and genotyping of duck hepatitis A virus subtypes 1 and 3 | |
CN112280899A (zh) | 猪星状病毒2型TaqMan荧光定量PCR试剂盒及其应用 | |
CN116814857A (zh) | 猫细小病毒及其试剂盒和荧光重组酶聚合酶扩增的方法 | |
Yu et al. | TaqMan-probe-based multiplex real-time RT-qPCR for simultaneous detection of GoAstV, GPV, and GoCV | |
CN114085929B (zh) | 一种用于检测非洲猪瘟病毒野毒株和疫苗株的试剂盒 | |
CN116179763A (zh) | 一种基于era技术的基因ⅰ型和基因ⅱ型黄头病毒多重快速检测方法及检测用引物和探针 | |
Major et al. | Rapid detection of DNA and RNA shrimp viruses using CRISPR-based diagnostics | |
CN115961102A (zh) | 基于era技术的对虾传染性肌肉坏死病毒的检测方法 | |
Rios et al. | Multi-target strategy for pan/foot-and-mouth disease virus (FMDV) detection: a combination of sequences analysis, in silico predictions and laboratory diagnostic evaluation | |
CN110684862B (zh) | 用于定量检测乙型肝炎病毒的微滴数字pcr试剂盒及检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240218 Address after: 572024 7th floor, building 1, UFIDA Industrial Park, Yazhou Bay science and Technology City, Yazhou District, Sanya City, Hainan Province Applicant after: Sanya Institute of Oceanography Ocean University of China Country or region after: China Applicant after: HEIBEI XINHAI AQUATIC BIOTECHNOLOGY Co.,Ltd. Address before: 572024 Building 10, Yonyou Industrial Park, Yazhou Bay Science and Technology City, Yazhou District, Sanya City, Hainan Province Applicant before: Sanya Institute of Oceanography Ocean University of China Country or region before: China |